(2R,6R)-Hydroxynorketamine for the Treatment of Neuropathic Pain

Clinical trial NCT05864053 · RECRUITING

Trial details

NCT number: NCT05864053
Sponsor: Rush University Medical Center
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pain, Neuropathic

Start date: 2024-09-19
Primary completion: 2027-04-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.